58 related articles for article (PubMed ID: 17611676)
41. Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.
Milatovic D; Montine TJ; Aschner M
Neurotoxicology; 2011 Jun; 32(3):312-9. PubMed ID: 21376752
[TBL] [Abstract][Full Text] [Related]
42. The COX-2/prostanoid signaling cascades in seizure disorders.
Rojas A; Chen D; Ganesh T; Varvel NH; Dingledine R
Expert Opin Ther Targets; 2019 Jan; 23(1):1-13. PubMed ID: 30484341
[TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase pathways.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Acta Biochim Pol; 2014; 61(4):639-49. PubMed ID: 25343148
[TBL] [Abstract][Full Text] [Related]
44. Prostanoids and Hair Follicles: Implications for Therapy of Hair Disorders.
Xu XG; Chen HD
Acta Derm Venereol; 2018 Mar; 98(3):318-323. PubMed ID: 29136266
[TBL] [Abstract][Full Text] [Related]
45. Prostanoids in the pathophysiology of human coronary artery.
Ozen G; Norel X
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():20-28. PubMed ID: 28347710
[TBL] [Abstract][Full Text] [Related]
46. Function of COX-2 and prostaglandins in neurological disease.
Liang X; Wu L; Wang Q; Hand T; Bilak M; McCullough L; Andreasson K
J Mol Neurosci; 2007 Sep; 33(1):94-9. PubMed ID: 17901552
[TBL] [Abstract][Full Text] [Related]
47. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
Moncada S; Vane JR
Drug Ther; 1982; ():37-65. PubMed ID: 7049651
[No Abstract] [Full Text] [Related]
48. Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.
Peinhaupt M; Sturm EM; Heinemann A
Front Med (Lausanne); 2017; 4():104. PubMed ID: 28770200
[TBL] [Abstract][Full Text] [Related]
49. Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.
Onguru O; Casey MB; Kajita S; Nakamura N; Lloyd RV
Endocr Pathol; 2005; 16(4):253-77. PubMed ID: 16627914
[TBL] [Abstract][Full Text] [Related]
50. Prostanoid Metabolites as Biomarkers in Human Disease.
Idborg H; Pawelzik SC
Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005592
[TBL] [Abstract][Full Text] [Related]
51. The enzymology of the human prostanoid pathway.
Biringer RG
Mol Biol Rep; 2020 Jun; 47(6):4569-4586. PubMed ID: 32430846
[TBL] [Abstract][Full Text] [Related]
52. [The effect of ionizing radiation on prostanoid metabolism].
Navrátil L; Pospísil J
Cas Lek Cesk; 1987 Apr; 126(14):428-30. PubMed ID: 3555829
[No Abstract] [Full Text] [Related]
53. Illuminating the lung regenerative potential of prostanoids.
Fortier SM; Penke LR; Peters-Golden M
Sci Adv; 2022 Mar; 8(12):eabp8322. PubMed ID: 35319993
[TBL] [Abstract][Full Text] [Related]
54. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
[TBL] [Abstract][Full Text] [Related]
55. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
Hata AN; Breyer RM
Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
[TBL] [Abstract][Full Text] [Related]
56. Roles of prostanoids in the pathogenesis of cardiovascular diseases.
Yuhki K; Kashiwagi H; Kojima F; Kawabe J; Ushikubi F
Int Angiol; 2010 Apr; 29(2 Suppl):19-27. PubMed ID: 20357745
[TBL] [Abstract][Full Text] [Related]
57. Possible cross-regulation of the E prostanoid receptors.
Tober KL; Thomas-Ahner JM; Maruyama T; Oberyszyn TM
Mol Carcinog; 2007 Aug; 46(8):711-5. PubMed ID: 17538953
[TBL] [Abstract][Full Text] [Related]
58. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
Naveh-Floman N; Moisseiev J
Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
